openPR Logo
Press release

Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)

06-22-2022 07:12 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Outset Medical, Inc. (NASDAQ: OM) shares over potential securities laws violations.

An investigation for investors in Outset Medical, Inc. (NASDAQ: OM) shares over potential securities laws violations.

An investigation was announced concerning potential securities laws violations by Outset Medical, Inc. in connection with certain statements.

Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series of statements by Outset Medical, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Jose, CA based Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis.
Outset Medical, Inc. reported that its annual Total Revenue rose from $49.93 million in 2020, to $102.6 million in 2021, and that its Net Loss increased from $121.49 million in 2020, to $131.93 million in 2021.

On June 13, 2022, Outset Medical, Inc. announced that "it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration's (FDA) review and clearance of a 510(k) the company submitted for changes made since the device's original March 2020 clearance."

Shares of Outset Medical, Inc. (NASDAQ: OM) declined from $40.51 per share on May 4, 2022, to as low as $13.25 per share on June 14, 2022.

Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: OM) here

News-ID: 2658544 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Outset

Deadline on September 6th coming up in Lawsuit for Investors in Outset Medical, …
A deadline is coming up on September 6, 2022 in the lawsuit filed for certain investors of Outset Medical, Inc. (NASDAQ: OM) over alleged securities laws violations by Outset Medical, Inc. (NASDAQ: OM. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and there are strict and short deadlines running. Deadline: September 6, 2022. NASDAQ: OM stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)
An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit alleged violations of Federal Securities Laws by Outset Medical, Inc. Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Jose, CA based Outset
Dialysis Equipment Market to 2028 |Teleflex Incorporated, B. Braun Melsungen AG, …
Market Research Hub (MRH) has carefully analyzed this research study titled Dialysis Equipment Market: High Demand for Continuous Renal Replacement Therapy Systems to be Observed During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Dialysis Equipment Market.
Hemodialysis Catheter Market – Utilisation Survey 2025 | Toray Medical Co., Lt …
Global Hemodialysis Catheter Market: Overview Hemodialysis catheters are being extensively used to meet the growing demand of hemodialysis, apheresis, infusion, and monitoring of central venous pressure along with high-pressure contrast injection patients. It is predominantly used for maintaining effective blood flow rate, which is estimated at 400 ml/min for at least 3 hours. The growing number of patients suffering from end-stage renal disease (ESRD) have increased the demand for hemodialysis to
Hemodialysis Catheter Market – Global Need Assumptions 2025 | Toray Medical Co …
Hemodialysis Catheter Market: Snapshot Hemodialysis catheters play a crucial role in the delivery of hemodialysis for renal replacement therapy in patients with end-stage renal diseases. The hemodialysis catheter can be used as a means for making permanent vascular access when access through arteriovenous (AV) fistula or AV graft may not be possible. The catheter is mostly used as tunneled catheter placed under the skin under one of the larger veins, preferably
Outset of Bio-based Polyethylene Terephthalate Products to Fire Up Demand in Com …
"The Report Global Polyethylene Terephthalate Market 2017-2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has recently added the report titled, “Global Polyethylene Terephthalate Market 2017-2021” to its offering. The report evaluates the key growth opportunities, trends, growth drivers, and restraints prevailing in the market. It also includes detailed discussions on value chain analysis, competitive landscape, market attractiveness, and supply